Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies

Strahlentherapie und Onkologie

Volumn 188, Issue 8, 2012, Pages 692-695

  Nieder, C ^a,b   Andratschke, N H ^c   Geinitz, H ^d   Grosu, A L ^e  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Brain metastases; Prognosis; Prognostic score; Radiotherapy

Indexed keywords

ARTICLE; BRAIN METASTASIS; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL EVALUATION; GRADED PROGNOSTIC ASSESSMENT; PRIMARY TUMOR; SCORING SYSTEM;

BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDIES;

EID: 84864632991     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0107-2     Document Type: Article

References (22)

1. Denham JW, Peters LJ, Johansen J et al (1999) Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol 52:157-164. (Pubitemid 29461083)
2. Dische SA, Saunders M, Barret A et al (1997) A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44:123-136. (Pubitemid 27345199)
3. Fu KK, Pajak TF, Trotti A, Jones CU et al (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7-16. (Pubitemid 30488207)
4. Goyal M, Shukla P, Gupta D et al (2009) Oral mucositis in morning vs. evening irradiated patients: a randomised prospective study. Int J Radiat Biol 85:504-509.
5. Kaanders JH, Van Daal WAJ, Hoogenraad WJ et al (1992) Accelerated fractionated radiotherapy for laryngeal cancer, acute and late toxicity. Int J Radiat Oncol Biol Phys 24:497-503.
6. Kubes J, Cvek J, Vondracek V et al (2011) Accelerated radiotherapy with concomitant boost technique (69.5 gy/5 weeks)-an alternative in the treatment of locally advanced head and neck cancer. Strahlenther Onkol 187:651-655.
7. MacKenzie R, Balogh J, Choo R et al (1999) Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of head and neck. Int J Radiat Oncol Biol Phys 45:589-595. (Pubitemid 29462637)
8. Maurer J, Hipp M, Schäfer C et al (2011) Dysphagia-Impact on quality of life after radio(chemo)therapy of head and neck cancer. Strahlenther Onkol 187:744-749.
9. Narayan S, Lehmann J, Coleman MA et al (2008) Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy. Int J Radiat Oncol Biol Phys 72:756-762.
10. O'Sullivan JM, Hollywood DP, Cody N et al (2002) Accelerated radiation therapy, seven fractions per week, for advanced head and neck cancer-A feasibility study. Clin Oncol 14:236-240.
11. Overgaard J, Hansen HS, Specht L et al (2003) Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362:933-940. (Pubitemid 37159288)
12. Poulsen M, Denham J, Spry N et al (1999) Acute toxicity and cost analysis of phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study. Australas Radiol 43:487-494. (Pubitemid 29526103)
13. Quinn B, Potting CMJ, Stone R et al (2008) Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. Eur J Cancer 44:61-72. (Pubitemid 350256936)
14. Semrau R, Temming S, Preuss SF et al (2011) Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel-A phase II study. Strahlenther Onkol 187:645-650.
15. Shah N, Saunders MI, Dische S (2000) A pilot study of postoperative CHART and CHARTWEL in head and neck cancer. Clin Oncol 12:392-396. (Pubitemid 32051524)
16. Skladowski K, Maciejewski B, Golen M et al (2006) Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial. Int J Radiat Oncol Biol Phys 66:706-713. (Pubitemid 44436685)
17. Sonis ST, Elting LS, Keefe D et al (2004) Perspectives on cancer therapy-induced mucosal injury. Cancer 100(Suppl):1995-2025.
18. Trotti A, Klotch D, Endicott J et al (1993) A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 26:181-182.
19. Trotti A, Bellm LA, Epstein JB et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253-262. (Pubitemid 36556043)
20. Wolff HA, Bosch J, Jung K et al (2010) High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer. Strahlenther Onkol 186:262-268.
21. Wygoda A, Maciejewski B, Skladowski K et al (2009) Pattern analysis of acute mucosal reactions in patients with head and neck cancer treated with conventional and accelerated irradiation. Int J Radiat Oncol Biol Phys 73:384-390.
22. Zouhair A, Azria D, Pasche P et al (2004) Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer. Radiother Oncol 709:183-188 (Pubitemid 38353018)